Skip to main content
DXCM logo

DXCM · Dexcom Inc · Investor Relations

Track DXCM — free
Market Cap
$31.08B
Shares
372.95M
Volume · Nov 13 3.01M Avg daily vol (3M) 4.23M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-17 14:00 UTC Jefferies Global Healthcare Conference Conference
2026-11-17 14:00 UTC Jefferies Global Healthcare Conference in London Conference

Recent news

Date Headline
2026-11-10 Dexcom Announces Upcoming Conference Presentation
2026-10-29 Dexcom Reports Third Quarter 2026 Financial Results
2026-10-28 Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November
2026-10-14 Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin
2026-10-07 Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time
2026-09-28 Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care
2026-09-14 Dexcom Promotes Jereme Sylvain to Chief Operating Officer
2026-09-10 Dexcom Appoints Glenn Boehnlein to Board of Directors
2026-09-01 Dexcom Announces Upcoming Conference Presentation
2026-07-30 Dexcom Reports Second Quarter 2026 Financial Results
2026-07-22 Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program
2026-07-13 Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes
2026-07-09 Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time
2026-06-23 Dexcom Further Advances Vision of Glucose Biosensing for All
2026-06-06 Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
2026-06-04 Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026
2026-05-14 Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day
2026-05-05 Dexcom to Host Investor Day on May 14, 2026
2026-04-30 Dexcom Reports First Quarter 2026 Financial Results
2026-04-02 Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
2026-03-11 Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
2026-02-26 Dexcom Appoints Rick Osterloh to Board of Directors
2026-02-25 Dexcom Announces Upcoming Conference Presentation
2026-02-12 Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results
2026-02-04 Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

Enhanced Smart Food Logging experience now provides nutritional breakdown of meals Advanced AI-enabled features will deliver easy meal tracking to transform daily metabolic health management Redesigned and personalized Daily Insights will reveal how daily performance and behaviors impact health Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users understand their glucose health and take steps in achieving their long-term health goals. The newest features will launch nationwide in the coming weeks. Enhanced Smart Food Logging experience now provides nutritional breakdown of meals Last year, Dexcom introduced AI-driven Smart Food Logging in Stelo, the first over-the-counter glucose biosensor cleared 1 by the FDA in the United States. Now the company has expanded this feature by integrating a comprehensive nutrition database that provides a breakdown of calories,

Past events

Date Event Type
2026-10-29 DexCom, Inc. Third Quarter 2026 Earnings Release Conference Call Earnings call
2026-09-09 Wells Fargo 21st Annual Healthcare Conference Conference
2026-07-30 DexCom, Inc. Second Quarter 2026 Earnings Release Conference Call Earnings call
2026-05-14 2026 Dexcom Investor Day Presentation
2026-04-30 DexCom, Inc. First Quarter 2026 Earnings Release Conference Call Earnings call
2026-03-02 Raymond James 47th Annual Institutional Investors Conference Conference
2026-02-12 DexCom, Inc. Fourth Quarter 2025 Earnings Release Conference Call Earnings call
2026-01-12 44th Annual J.P. Morgan Healthcare Conference Conference
2025-10-30 DexCom, Inc. Third Quarter 2025 Earnings Release Conference Call Earnings call
2025-09-10 Baird 2025 Global Healthcare Conference Conference
2025-09-03 2025 Wells Fargo Healthcare Conference Conference
2025-07-30 DexCom, Inc. Second Quarter 2025 Earnings Release Conference Call Earnings call
2025-05-01 DexCom, Inc. First Quarter 2025 Earnings Release Conference Call Earnings call
2025-03-04 Raymond James Institutional Investor Conference Conference
2025-02-13 DexCom, Inc. Fourth Quarter 2024 Earnings Release Conference Call Earnings call
2025-01-13 43rd Annual J.P. Morgan Healthcare Conference Conference
2024-10-24 DexCom, Inc. Third Quarter 2024 Earnings Release Conference Call Earnings call
2024-09-04 Wells Fargo 2024 Healthcare Conference Conference
2024-07-25 DexCom, Inc. Second Quarter 2024 Earnings Release Conference Call Earnings call
2024-06-05 William Blair 44th Annual Growth Stock Conference Conference
2024-04-25 DexCom, Inc. First Quarter 2024 Earnings Release Conference Call Earnings call
2024-03-05 Raymond James Institutional Investors Conference Conference
2024-02-08 DexCom, Inc. Fourth Quarter 2023 Earnings Release Conference Call Earnings call
2024-01-08 42nd annual J.P. Morgan Healthcare Conference Conference
2023-11-29 Piper Sandler 35th Annual Healthcare Conference Conference

Source: https://investors.dexcom.com/overview/default.aspx

Key facts CIK 1093557 CUSIP 252131107 13F (30d) 842 filings 771 filers Visit website Investor relations